Expression of Ezrin,HGF,C-met in pancreatic cancer and non-cancerous pancreatic tissues of rats

被引:7
|
作者
Xing-Guo Tan and Zhu-Lin Yang Research Laboratory of Hepatobiliary Diseases
机构
关键词
pancreatic neoplasms; animal model; Ezrin; hepatocyte growth factor; C-met;
D O I
暂无
中图分类号
R735.9 [胰腺肿瘤];
学科分类号
100214 ;
摘要
BACKGROUND:Recent studies have confirmed that the expression of Ezrin,hepatocyte growth factor(HGF)and its receptor(C-met)is related to the genesis,progress,invasion and metastasis of some malignant tumors.Researches have also found that the biological function of Ezrin is closely related to HGF/C-met in malignant tumors.However,there is no report on the expression levels of Ezrin,HGF and C-met in rat pancreatic cancer induced by dimethylbenzanthracene (DMBA).This study aimed to detect the expression of Ezrin, HGF and C-met in rat pancreatic cancer and non-cancerous pancreatic tissues,and assess its effect in cancer induction by DMBA. METHODS:Ninety Sprague-Dawley rats were divided into 3 groups randomly:40 in a pancreatic cancer model group (group A),40 in a trichostatin A(TSA)intervention group (group B),and 10 in a control group(group C).DMBA was directly implanted into the parenchyma of rat pancreas in group A+group B.The rats of group B were treated with 1 ml of TSA saline solution(1μg/ml)via intraperitoneal injection weekly.The carcinogenesis of rats executed within 3-5 months in groups A and B was observed by macrograph and microscopy. Meanwhile,the rats in group C were executed within 5 months. The EnVision TM immunohistochemistry for detecting the expression levels of Ezrin,HGF and C-met was used in paraffinembedded sections of the pancreatic specimens. RESULTS:The incidence of pancreatic cancer in group A was 48.6%and in group B 33.3%.The maximal diameter of tumor mass was significantly larger in group A than that in group B(P<0.05).No pathological changes were observed , in the pancreas of group C and other main organs of groups A and B.The positive rates of Ezrin,HGF and C-met were significantly higher in ductal adenocarcinoma than in non- cancerous pancreatic tissues of groups A and B(P<0.01).The positive rates of Ezrin,HGF and C-met were significantly higher in ductal adenocarcinoma of group A than those in non- cancerous pancreatic tissues of group A(P<0.05),but there was no significant difference in group B(P>0.05).The positive rates of Ezrin,HGF and C-met in non-cancerous pancreatic tissues proved mild to severe atypical hyperplasia of the ductal epithelia.The pancreas of group C and 2 cases of fibrosarcoma showed the negative expression of Ezrin,HGF and C-met.There was a trend of consistency in the expression of Ezrin,HGF and C-met in ductal adenocarcinoma(P<0.05 or P<0.01). CONCLUSIONS:DMBA directly implanted into the parenchyma of the pancreas can produce a model of pancreatic cancer with a high incidence in a short time.TSA might inhibit the carcinogenesis and growth of pancreatic cancer,and its effects may be related to the inhibition of the expression of Ezrin,HGF and C-met during the process.Ezrin,HGF and C-met may have positive effects on the carcinogenesis of rat pancreas.
引用
收藏
页码:639 / 644
页数:6
相关论文
共 50 条
  • [1] Expression of Ezrin, HGF, C-met in pancreatic cancer and non-cancerous pancreatic tissues of rats
    Tan, Xing-Guo
    Yang, Zhu-Lin
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2010, 9 (06) : 639 - 644
  • [2] Expression of DNA-repair proteins and their significance in pancreatic cancer and non-cancerous pancreatic tissues of Sprague–Dawley rats
    Xing-guo Tan
    Zhu-lin Yang
    Le-ping Yang
    Xiong-ying Miao
    World Journal of Surgical Oncology, 12
  • [3] Targeting HGF/c-MET Axis in Pancreatic Cancer
    Pothula, Srinivasa P.
    Xu, Zhihong
    Goldstein, David
    Pirola, Romano C.
    Wilson, Jeremy S.
    Apte, Minoti, V
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (23) : 1 - 18
  • [4] Correlation between hypoxia and HGF/c-MET expression in the management of pancreatic cancer
    Sharma, Rishav
    Malviya, Rishabha
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2023, 1878 (03):
  • [5] Expression of DNA-repair proteins and their significance in pancreatic cancer and non-cancerous pancreatic tissues of Sprague-Dawley rats
    Tan, Xing-guo
    Yang, Zhu-lin
    Yang, Le-ping
    Miao, Xiong-ying
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2014, 12
  • [6] Targeting the HGF/c-MET pathway: stromal remodelling in pancreatic cancer
    Pothula, Srinivasa P.
    Xu, Zhihong
    Goldstein, David
    Merrett, Neil
    Pirola, Romano C.
    Wilson, Jeremy S.
    Apte, Minoti V.
    ONCOTARGET, 2017, 8 (44) : 76722 - 76739
  • [7] Pancreatic Stellate Cells Facilitate Perineural Invasion of Pancreatic Cancer via HGF/c-Met Pathway
    Nan, Ligang
    Qin, Tao
    Xiao, Ying
    Qian, Weikun
    Li, Jie
    Wang, Zheng
    Ma, Jiguang
    Ma, Qingyong
    Wu, Zheng
    CELL TRANSPLANTATION, 2019, 28 (9-10) : 1289 - 1298
  • [8] Pancreatic Cancer Treatment Targeting the HGF/c-MET Pathway: The MEK Inhibitor Trametinib
    Kim, Junyeol
    Lee, Tae Seung
    Lee, Myeong Hwan
    Cho, In Rae
    Ryu, Ji Kon
    Kim, Yong-Tae
    Lee, Sang Hyub
    Paik, Woo Hyun
    CANCERS, 2024, 16 (05)
  • [9] Expression of Ezrin, HGF and C-met and its Clinicopathological Significance in the Benign and Malignant Lesions of the Gallbladder
    Yang, Leping
    Guo, Tanxing
    Jiang, Song
    Yang, Zhulin
    HEPATO-GASTROENTEROLOGY, 2012, 59 (118) : 1769 - 1775
  • [10] HGF/c-Met Inhibition as Adjuvant Therapy Improves Outcomes in an Orthotopic Mouse Model of Pancreatic Cancer
    Pang, Tony C. Y.
    Xu, Zhihong
    Mekapogu, Alpha Raj
    Pothula, Srinivasa
    Becker, Therese
    Corley, Susan
    Wilkins, Marc R.
    Goldstein, David
    Pirola, Romano
    Wilson, Jeremy
    Apte, Minoti
    CANCERS, 2021, 13 (11)